Thalidomide and irradiation combination therapy increases substance P levels in vitro

about

Cyproheptadine, an antihistaminic drug, inhibits proliferation of hepatocellular carcinoma cells by blocking cell cycle progression through the activation of P38 MAP kinase.

P2860

Q35248527-495D7CCA-C519-4C2F-8997-12BB43BDF9D5

P2860

Thalidomide and irradiation combination therapy increases substance P levels in vitro

Item

http://www.wikidata.org/entity/Q36230673

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Thalidomide and irradiation combination therapy increases substance P levels in vitro

@ast

Thalidomide and irradiation combination therapy increases substance P levels in vitro

@en

type

Item

label

Thalidomide and irradiation combination therapy increases substance P levels in vitro

@ast

Thalidomide and irradiation combination therapy increases substance P levels in vitro

@en

prefLabel

Thalidomide and irradiation combination therapy increases substance P levels in vitro

@ast

Thalidomide and irradiation combination therapy increases substance P levels in vitro

@en

P1476

Thalidomide and irradiation combination therapy increases substance P levels in vitro

@en

P2093

Aylin Fidan Korcum

http://www.w3.org/2001/XMLSchema#string

Ece Şimşek Oz

http://www.w3.org/2001/XMLSchema#string

Esra Aydemir

http://www.w3.org/2001/XMLSchema#string

Kayahan Fiskin

http://www.w3.org/2001/XMLSchema#string

P2860

Thalidomide is an inhibitor of angiogenesis

Combination oral antiangiogenic therapy with thalidomide and sulindac inhibits tumour growth in rabbits

Structure, expression, and some regulatory mechanisms of the rat preprotachykinin gene encoding substance P, neurokinin A, neuropeptide K, and neuropeptide gamma

Low doses of ionizing radiation promote tumor growth and metastasis by enhancing angiogenesis

A phase II trial of thalidomide in patients with refractory endometrial cancer and correlation with angiogenesis biomarkers: a Gynecologic Oncology Group study.

Conformational analysis of the tachykinins in solution: substance P and physalaemin.

Increased expression of preprotachykinin-I and neurokinin receptors in human breast cancer cells: implications for bone marrow metastasis

On the birth of breast cancer.

Angiogenic tumor markers, antiangiogenic agents and radiation therapy.

Breast cancer prevention--clinical trials strategies involving aromatase inhibitors.

P304

529-535

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2011.216

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22977536

http://www.w3.org/2001/XMLSchema#string

P921

thalidomide

P932

3440713

http://www.w3.org/2001/XMLSchema#string

Thalidomide and irradiation combination therapy increases substance P levels in vitro

about

P2860

P2860

Thalidomide and irradiation combination therapy increases substance P levels in vitro

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932